Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2024.05.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Alberto Zanetto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, Factor XI. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero dell'Istruzione dell'Università e della Ricerca.
Abstract (Originalsprache)
INTRODUCTION: Factor XI (FXI) is associated with thrombosis in patients without liver disease, but it alterations and prognostic value in cirrhosis are uncertain. PATIENTS AND METHODS: We studied a prospective cohort of cirrhosis patients determining FXI and its association with portal vein thrombosis (PVT), bleeding, and hepatic decompensation/ACLF during 1-year follow-up. Odds ratios (OR) and 95 % CIs were calculated using logistic regression. RESULTS: We included 183 patients (Child-Pugh [CP] A/B/C 57/59/57). FXI was reduced in cirrhosis, decreasing with CP stage (78 % [66-94] vs. 58 % [44-78] vs. 41 % [30-52] in CP A, B, and C, respectively; p < 0.001). FXI was correlated with MELD score (rho: -0.6, p < 0.001), INR (rho: -0.6, p < 0.001), and platelet count (rho: 0.4, p < 0.001). Sixteen patients (8.7 %) experienced PVT, which only predictor was baseline platelet count (OR: 0.94; CI95 %: 0.91-0.97, p < 0.001). Bleeding occurred in 7 patients (3.8 %). Cirrhosis severity, platelet count, fibrinogen, and FXI (60% vs. 78 %; p = 0.2) were comparable between bleeding and non-bleeding individuals. Finally, no association was found between FXI and hepatic decompensation/ACLF, which were predicted by lower albumin and platelet count, respectively. CONCLUSION: FXI seems not to be responsible for thrombosis and cirrhosis progression. The lack of association between low FXI and bleeding events, however, indirectly opens to future studies evaluating FXI inhibitors in cirrhosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.
- Department of Medicine (DIMED), University of Padova, Padova, Italy; First Chair of Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital, Padova, Italy.
- First Chair of Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital, Padova, Italy.
- Department of Medicine (DIMED), University of Padova, Padova, Italy; First Chair of Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital, Padova, Italy. Electronic address: paolo.si…
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Ministero dell'Istruzione dell'Università e della Ricerca
Zitieren
APA
Zanetto, A., Campello, E., Spiezia, L., Gavasso, S., Bulato, C., Burra, P., Russo, F. P., Senzolo, M., & Simioni, P. (2024). Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.05.020
Vancouver
Zanetto A, Campello E, Spiezia L, Gavasso S, Bulato C, Burra P, et al. Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.05.020
BibTeX
@article{Zanetto2024,
author = {Zanetto, Alberto and Campello, Elena and Spiezia, Luca and Gavasso, Sabrina and Bulato, Cristiana and Burra, Patrizia and Russo, Francesco Paolo and Senzolo, Marco and Simioni, Paolo},
title = {Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2024.05.020}
}
EUVIMED